Top Republican on China panel objects to resumption of Nvidia H20 chip shipments

The chairman of the House Select Committee on China has formally objected to the Commerce Department's decision allowing Nvidia to resume H20 AI chip sales to China, reversing a prior export ban. This controversial move, which saw Nvidia shares turn negative, draws bipartisan legislative criticism over concerns that the chips could significantly advance China's AI capabilities and military. The Commerce Department linked the decision to broader rare earth negotiations, but legislators warn it risks undermining U.S. national security and technological leadership.

Analysis

Nvidia faces renewed regulatory and geopolitical uncertainty following a formal objection from the chairman of the House Select Committee on China regarding the resumption of H20 AI chip sales to the country. The U.S. Commerce Department's decision to reverse a prior export ban, a move it linked to broader negotiations on rare earths, has drawn sharp bipartisan criticism over national security concerns. Legislators warn that allowing sales of the H20 chip, which was reportedly instrumental in developing a notable AI model by Chinese firm DeepSeek, could advance China's military AI and global competitiveness. This political pushback injects significant risk into what Nvidia considers an important revenue stream and led to an immediate negative turn in its share price, reflecting investor apprehension about the stability of U.S. trade policy and its impact on the company's access to the Chinese market.

Key Decisions for Investors

• Investors in Nvidia should closely monitor for any official response from the Commerce Department or further legislative action, as the political opposition creates significant uncertainty for a key revenue stream.
• The heightened geopolitical risk warrants a reassessment of near-term revenue forecasts from Nvidia's China operations, as the permission to sell H20 chips is now clearly contested and could be reversed.
• Given the immediate negative stock reaction and the cautious sentiment, it may be prudent to evaluate exposure to the stock, as the policy conflict introduces volatility and a direct threat to the company's prior guidance on its China business.